EMULVIT D
Natural health product licensed in Canada
- Licence holder
- PHARCON Inc.
- NPN or DIN-HM
- 80071728
- Status
- Active licence
- Licence date
- 5 August 2016
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 12.5 microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 500 Unités internationales | Not calculated |
Non-medicinal ingredients
PEG-40 Hydrogenated Castor Oil, BHT, Eau purifiée, d-alpha tocophérol, Disodium citrate, Sorbate de potassium, Huile de Mentha Piperita (Menthe poivrée), Sucralose, Huile de coco fractionnée, Polysorbate 60, d-Sorbitol, Lécithine, d-alpha tocopheryl acetate, Alcool de grain, Acid citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | maximum: 13 years | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | 1 Tous les jours |
| Adultes | Not specified | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of food health. Helps to prevent vitamin D deficiency. Helps in the absorption and use of calcium. Helps in the development and maintenance of bones, Helps in the development and maintenance of teeth. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80071728
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.